Fortrea Holdings Inc. Common Stock (FTRE)
Health Care – SERVICES-MEDICAL LABORATORIES
- CEO
- Anshul Thakral
- Headquarters
- United States
- Employees
- 14,000
- Market Cap
- $2.1B
About Fortrea Holdings Inc. Common Stock
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
SentiSense also tracks daily options readings for Fortrea Holdings Inc. Common Stock: IV rank, put/call percentile, 25-delta skew, open-interest walls, and unusually active contracts, each measured against the stock's own history. Sign in to view them.
Fortrea Holdings Inc. Common Stock stock analysis, sentiment tracking, and market intelligence on SentiSense.